DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20211346

Efficacy of vaginal dilator use in preventing vaginal stenosis among cervical and endometrial cancer patients underwent radiotherapy

Varghese Mathew K., Raphael Jomon C., Antony Febin, Mohan Malini, Gopu Paul

Abstract


Background: Vaginal dilators (VD) are effective in the prevention of vaginal stenosis in patients undergoing pelvic radiotherapy for gynaecological malignancies. This study was aimed to assess the efficacy of VD use in preventing post radiotherapy vaginal stenosis in cervical and endometrial cancer patients.

Methods: A cohort study was designed among patients (20-70 years) with biopsy proven endometrial and cervical carcinoma who underwent pelvic radiotherapy were included. Patients with cervical carcinoma (FIGO stage-IA to IVA), endometrial carcinoma (FIGO stage IB grade III, FIGO stage II), histology of squamous cell carcinoma, adenocarcinoma and performance score-ECOG 1 were included in the study. Assessment included clinical history, general examination, pelvic examination at 3 monthly intervals till 1 year. Grading of vaginal stenosis was assessed using LENT SOMA grading system.

Results: A total of 42 patients with 20 patients using vaginal dilators and 22 patients who refused to use VD were assigned. It was effective for 60% of VD users compared to 20% of nonusers (p=0.007) at 9 months follow up. While at 12 months follow up, it was effective for 58% of VD users compared to 16.6% of nonusers (p=0.066). Percent adherence was maximum in the 1st and 2ndquarter and declined to 61% by the 4th quarter. The total adherence was 97%.

Conclusions: There was 55% vs 22.7% effectiveness to prevent the vaginal stenosis among VD users.  All patients need proper counselling, motivation and support for regular usage of VD which will ultimately help in reducing the incidence of vaginal stenosis.


Keywords


Brachytherapy, Cervical cancers, Endometrial cancer, Pelvic radiotherapy, VD, Vaginal stenosis

Full Text:

PDF

References


Fowler JR, Jack BW. Cancer, Cervical. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431093/. Accessed on 2020 Sep 10.

Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian Journal of Medical and Paediatric Oncology. 2016;37(4):278.

Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2019.

Bakker R, TerKuile M, Vermeer W, Nout R, Mens J, Van Doorn L et al. Sexual Rehabilitation After Pelvic Radiotherapy and Vaginal Dilator Use: Consensus Using the Delphi Method. Int J Gynecol Cancer. 2014;24(8):1499-1506.

Morris L, Do V, Chard J, Brand A. Radiation-induced vaginal stenosis: current perspectives. Int J Women's Health. 2017;9:273-9.

National Forum of Gynecological Oncology Nurses. Best Practice guidelines on the use of vaginal dilators in women receiving pelvic radiotherapy. Oxon: Published by Owen Mumford, 2005.

Johnson N, Miles T, Cornes P. Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG: An Int J Obstetr Gynecol. 2010;117(5):522-31.

Jensen P, Groenvold M, Klee M, Thranov I, Petersen M, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiation Oncol Biol Physics. 2003;56(4):937-49.

Cullen K, Fergus K, DasGupta T, Fitch M, Doyle C, Adams L. From “Sex Toy” to Intrusive Imposition: A Qualitative Examination of Women's Experiences with Vaginal Dilator Use Following Treatment for Gynecological Cancer. J Sexual Med. 2012;9(4):1162-73.

Small W, Mell L, Anderson P, Creutzberg C, De Los Santos J, Gaffney D et al. Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical Cancer. Int J Radiation Oncol Biol Physics. 2008;71(2):428-34.

Lim K. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011;79(2):348-55.

Mirabeau-Beale K, Hong T, Niemierko A, Ancukiewicz M, Blaszkowsky L, Crowley E et al. Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer. Practical Radiation Oncol. 2015;5(3):e113-8.

Hartman P, Diddle A. Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer. 1972;30(2):426-9.

Law E, Kelvin J, Thom B, Riedel E, Tom A, Carter J et al. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radioth Oncol. 2015;116(1):149-55.

Eltabbakh G, Piver M, Hempling R, Shin K. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial. Int J Radiation Oncol Biol Physics. 1997;38(2):373-80.

Velaskar SM, Martha R, Mahantashetty U, Badakare JS, Shrivastava SK. Use of indigenous vaginal dilator in radiation induced vaginal stenosis. Indian J Occupational Therapy. 2007;34(1):3-6.

Brand A, Bull C, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006;16(1):288-93.

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Akiyama H et al. Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer. J Gynec Oncol. 2015;26(3):179.

Gondi V, Bentzen S, Sklenar K, Dunn E, Petereit D, Tannehill S et al. Severe Late Toxicities Following Concomitant Chemoradiotherapy Compared to Radiotherapy Alone in Cervical Cancer: An Inter-era Analysis. Int J Radiation Oncol Biol Physics. 2012;84(4):973-82.

Jeffries S, Robinson J, Craighead P, Keats M. An effective group psychoeducational intervention for improving compliance with vaginal dilation: A randomized controlled trial. Int J Radiation Oncol Biol Physics. 2006;65(2):404-411.

Shrivastava S, Mahantshetty U, Narayan K. Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer. International J Gyneccol Obstetrics. 2012;119:S155-9.

Kirchheiner K, Nout R, Lindegaard J, Haie-Meder C, Mahantshetty U, Segedin B et al. Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol. 2016;118(1):160-6.